In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood. (Q50547235)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21275998%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21275998%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21275998%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Jose A Cancelas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21275998%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Neeta Rugg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21275998%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Dana Fletcher

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21275998%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

P Gayle Pratt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21275998%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

D Nicole Worsham

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21275998%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Susan K Dunn

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21275998%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Susanne Marschner

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21275998%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Heather L Reddy

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21275998%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

28 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21275998%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21275998%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21275998%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21275998%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

1460-1468

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21275998%20AND%20SRC:MED&resulttype=core&format=json

Current status of solvent/detergent-treated frozen plasma

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

An action spectrum of the riboflavin-photosensitized inactivation of Lambda phage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

Morphology of Stored, Rejuvenated Human Erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

Successful in vivo recovery and extended storage of additive solution (AS)-5 red blood cells after deglycerolization and resuspension in AS-3 for 15 days with an automated closed system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

Improved post-transfusion quality of density separated AS-3 red cells after extended storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

The influence of riboflavin photochemistry on plasma coagulation factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

Production of pathogen-inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

Viability of red cells prepared with S-303 pathogen inactivation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

Treatment of whole blood (WB) and red blood cells (RBC) with S-303 inactivates pathogens and retains in vitro quality of stored RBC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

Platelet glycolytic flux increases stimulated by ultraviolet-induced stress is not the direct cause of platelet morphology and activation changes: possible implications for the role of glucose in platelet storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

The regulation of glycolysis in human erythrocytes. The dependence of the glycolytic flux on the ATP concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

Fresh whole blood transfusion: a controversial military practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X

Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03027.X